Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Non-antithrombotic therapy after TAVI (NAPT trial)
jRCTs031220614Active, not recruiting
- Sponsor
- Edwards Lifesciences
- Start
- Apr 2023
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Randomised trial of aspirin in aortic stenosis (AS) and postprocedural state after transcatheter aortic valve implantation (2 arms), sponsored by Edwards Lifesciences. Primary endpoint: Primary composite endpoint. Started Apr 2023; status: active, not recruiting.
02
Drugs
aspirin
03
Conditions
aortic stenosis (AS)postprocedural state after transcatheter aortic valve implantation
Beyond the preview
Go deeper on jRCTs031220614.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031220614.